Document ID: chunk:federal_register_of_legislation:F2022L00012:reg:9:p2
Version: federal_register_of_legislation:F2022L00012
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 6925–9789

debris or dust contaminated with asbestos fibres already present in an enclosed space may result in exposure to respirable asbestos fibres.
(9)          inhaling respirable asbestos fibres in an open environment, at the time material containing asbestos was being applied, removed, cut, drilled, dislodged or disturbed:
(a)          for a cumulative period of at least 3,000 hours before the clinical onset of malignant neoplasm of the colon or rectum; and
(b)          where the first inhalation of asbestos fibres commenced at least 5 years before the clinical onset of malignant neoplasm of the colon or rectum;
            Note: Disturbance of debris or dust contaminated with asbestos fibres already present in an open environment may result in exposure to respirable asbestos fibres.
(10)      having smoked tobacco products:
(a)          in an amount of at least 15 pack-years before the clinical onset of malignant neoplasm of the colon or rectum; and
(b)          commencing at least 5 years before the clinical onset of malignant neoplasm of the colon or rectum; and
         if smoking has ceased before the clinical onset of malignant neoplasm of the colon or rectum, then that onset occurred within 30 years of cessation;
Note: one pack-year is defined in the Schedule 1 - Dictionary.
(11)      consuming at least 250 kilograms of alcohol before the clinical onset of malignant neoplasm of the colon or rectum;
            Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(12)      being overweight or obese for at least 5 years within the 30 years before the clinical onset of malignant neoplasm of the colon or rectum;
Note: being overweight or obese is defined in the Schedule 1 - Dictionary.
(13)      having diabetes mellitus for at least 5 years before the clinical onset of malignant neoplasm of the colon or rectum;
(14)      having a solid organ transplant at least 5 years before the clinical onset of malignant neoplasm of the colon or rectum;
(15)      having chronic schistosomiasis involving the affected part of the colon or rectum for at least 5 years before the clinical onset of malignant neoplasm of the colon or rectum;
(16)      having a ureterosigmoidostomy involving the affected part of the sigmoid colon at least 5 years before the clinical onset of malignant neoplasm of the colon or rectum;
(17)      having psoriasis at the time of the clinical onset of malignant neoplasm of the colon or rectum;
(18)      having sarcoidosis at the time of the clinical onset of malignant neoplasm of the colon or rectum;
(19)      having bilateral oophorectomy at least 5 years before the clinical onset of malignant neoplasm of the colon or rectum;
(20)      having bilateral orchiectomy at least 5 years before the clinical onset of malignant neoplasm of the